Definitive Contract 75F40124C00109
Award Date 8/26/24
Potential Completion Date 8/27/25
Potential Value $1.2M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $3.27 million definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for professional services support to the Center for Drug Evaluation and Research on August 21, 2024. The contract uses direct 8(a) award authority with no competitive set-aside. The base term runs 12 months with an ultimate completion date of July 16, 2026. Place of performance is Reston, VA. The contract is structured as a labor-hour engagement. In FY2024,...
- <p>The Food and Drug Administration awarded a $4.198 million definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for supply chain technical support services to the Center for Drug Evaluation and Research (CDER) on August 28, 2025, under a direct 8(a) award.</p> <p>The contract is a labor-hour type with a 9.5-month base period and two 12-month options, extending through June 15, 2028. Place of performance is Beltsville, Maryland.</p>
- The Food and Drug Administration awarded a definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for shipping, receiving, printing support, and administrative support services to the Office of Regulatory Affairs Office of Training, Education, and Development on September 17, 2024, under an 8(a) sole-source set-aside with a ceiling value of $409,085.88. Work is performed in Reston, Virginia, under a labor-hours pricing structure. The contract extends through March...
- The Food and Drug Administration (FDA) awarded an 8(a) direct contract to Aneon Brillient, LLC on August 2, 2024, for professional services supporting the Center for Drug Evaluation and Research (CDER). The definitive labor-hour contract has a 12-month base period with a 9-month option and a total ceiling value of approximately $4.3 million. Work will be performed in Calverton, Maryland, with an ultimate completion date of May 31, 2026. This award was not set aside for small businesses but...
- The Food and Drug Administration awarded a $182,302.83 definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for quality management system services on July 17, 2024, under an 8(a) sole-source set-aside. The contract is a one-year labor-hour engagement supporting the Center for Drug Evaluation and Research, Office of Pharmacy, and is structured as time-and-materials pricing. Work is performed in St. Louis, Missouri. The ultimate completion date is August 6, 2025.
- <p>The Food and Drug Administration awarded a $144,540.21 labor-hour definitive contract to Aneon Brillient, LLC for additive manufacturing of medical products core facility support on May 23, 2024, under an 8(a) sole-source set-aside.</p> <p>Aneon Brillient, LLC is an SBA-certified 8(a) joint venture, minority-owned small disadvantaged business. Place of performance is Silver Spring, MD. The contract ceiling is $144,540.21 with an ultimate completion date of June 30, 2026.</p>
- The Food and Drug Administration (FDA) awarded an 8(a) sole source contract to Aneon Brillient, LLC, a minority-owned, SBA-certified small disadvantaged business based in Reston, Virginia, to provide administrative staffing services to the Center for Drug Evaluation and Research (CDER). The definitive labor-hour contract has a 12-month base period with a one-year option, a ceiling value of $186,092.22, and an ultimate completion date of August 24, 2026. Work will be performed in St. Louis,...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The contract is for $164,005.68 to provide communications support services for the Immediate Office of the FDA Commissioner, with a period of performance through July 13, 2026. Aneon Brillient, LLC is a limited liability company based in Reston, Virginia that specializes in providing...
- <p>The Food and Drug Administration (FDA) awarded a 1-year, firm fixed price type contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture, to provide program support staff for the FDA's Office of Global Policy and Strategy. This is a direct 8(a) sole source award with a ceiling value of $152,077.08. The contract will be performed in Calverton, Maryland and has a completion date of June 12, 2025.</p>
- The Food and Drug Administration (FDA) awarded an 8(a) sole source, stand-alone labor-hour contract to Aneon Brillient, LLC, a minority-owned, SBA-certified 8(a) joint venture based in Reston, Virginia, for professional services supporting the Oncology Center of Excellence. The contract, with a ceiling value of $1.9M, was awarded on August 12, 2026, and extends through August 11, 2027. Work will be performed in Silver Spring, Maryland. As a small disadvantaged business, Aneon Brillient leverages...